Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × olaparib × Clear all

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT04550104 2025-12-19

CONCORDE

Phase 1 Recruiting

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03334617 2025-10-27

HUDSON

Phase 2 Active not recruiting

528 enrolled 16 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02498613 2025-09-25

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

Phase 2 Active not recruiting

122 enrolled 16 charts

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03568656 2025-08-08

Study to Evaluate CCS1477 in Advanced Tumours

Phase 1/2 Completed

220 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01513174 2024-06-28

GOAL

Phase 1/2 Completed

186 enrolled 17 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01788332 2018-10-26

Phase 2 Unknown

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02679963 2017-08-01

PIPSeN

Phase 2 Unknown

600 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

QLS5132 Combination Therapy in Advanced Solid Tumors

CONCORDE

HUDSON

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

Study to Evaluate CCS1477 in Advanced Tumours

GOAL

PIN

PIPSeN